CSIMarket
 


Biomimetic Therapeutics, Inc.  (BMTI)
Other Ticker:  
 

Biomimetic Therapeutics's Long Term Debt to Equity

BMTI's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth


Due to long-term debt repayement of -24.09% Biomimetic Therapeutics improved Long Term Debt to Equity in third quarter 2012 to 0, a new company low.

Within Medical Equipment & Supplies industry in the third quarter 2012, 3 other companies have achieved lower Long Term Debt to Equity than Biomimetic Therapeutics in the III Quarter 2012. While Long Term Debt to Equity total ranking has improved so far in the third quarter 2012 to 52, from total ranking in the second quarter 2012 at 62 .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt BMTI´s has?
What is the structure of BMTI´s Equity?


BMTI Long Term Debt to Equity (Sep 30 2012)
III. Quarter
(Jun 30 2012)
II. Quarter
(Mar 31 2012)
I. Quarter
(Dec 31 2011)
IV. Quarter

Y / Y Equity Change - - - - -
Y / Y Long Term Debt Change - - - - -
Long Term Debt to Equity MRQ 0 0 0 0 -
BMTI's Total Ranking # 52 # 62 # 62 # 0 #
Seq. Equity Change -8.93 % -11.6 % -9.63 % - -
Seq. Long Term Debt Change -24.09 % -19.34 % -16.13 % - -



Long Term Debt to Equity third quarter 2012 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 4
Healthcare Sector # 7
Overall Market # 52


Long Term Debt to Equity Statistics
High Average Low
0 0 0
(Dec 31 2011)   (Sep 30 2012)




Financial Statements
Biomimetic Therapeutics's Equity $ 39 Millions Visit BMTI's Balance sheet
Biomimetic Therapeutics's Long Term Debt $ 0 Millions Visit BMTI's Balance sheet
Source of BMTI's Sales Visit BMTI's Sales by Geography


Cumulative Biomimetic Therapeutics's Long Term Debt to Equity

BMTI's Long Term Debt to Equity for the trailling 12 Months

BMTI Long Term Debt to Equity

(Sep 30 2012)
III. Quarter
(Jun 30 2012)
II. Quarter
(Mar 31 2012)
I. Quarter
(Dec 31 2011)
IV. Quarter

Y / Y Equity TTM Growth - - - - -
Y / Y Long Term Debt TTM Growth - - - - -
Long Term Debt to Equity TTM 0 0 0 0 -
Total Ranking TTM # 14 # # # #
Seq. Equity TTM Growth -8.93 % -11.6 % -9.63 % - -
Seq. Long Term Debt TTM Growth -24.09 % -19.34 % -16.13 % - -


On the trailing twelve months basis Due to long-term debt repayement of -24.09% Biomimetic Therapeutics